« Previous
Next »
Clinics in Dermatology
Volume 26, Issue 5
, Pages
486-502
, September 2008
Tumor necrosis factor antagonists in the therapy of psoriasis
To access this article, please choose from the options below
☆ R. M. has received travel grants from Essex (Munich, Germany) and Wyeth (Münster, Germany). M. P. S. has received lecture fees from Serono (Munich, Germany), Wyeth, Essex, and Abbott (Wiesbaden, Germany), and research grants from Schering/Berlex (Richmond, Calif). K. R. has served as a consultant and paid speaker for Abbott, Biogen Idec (Tsamaning, Germany), Centocor (Horsham, PA), Essex, Schering-Plough (Kenilworth, NJ), Serono, and Wyeth. He has also received grant funding from Biogen Idec.
PII: S0738-081X(07)00254-4
doi: 10.1016/j.clindermatol.2007.10.030
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Clinics in Dermatology
Volume 26, Issue 5
, Pages
486-502
, September 2008
